Juris Shibayama, MD
Orthopaedic Surgery of the Spine · Smyrna, TNNPI 1992758981
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.2%), travel and lodging and royalties or licence payments — rather than concentrated in one kind of arrangement. Stryker accounts for 67.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $17,174 and has fallen 71.2% since, to $4,947 in 2025.
Across 106 payments — averaging $380.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$27K
- Globus Medical$6K
- Arthrex$3K
- Music City Medical Technologies, LLC$2K
- Zimvie Inc.$893
- Zimmer Biomet$436
- plus $517 from 4 others
What the payments were for
- Royalty or licence$5,97815%
- Consulting fees$23,87559%
- Travel & lodging$6,13415%
- Food & beverage$4,32311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 34 | $27,278 |
| Globus Medical | 21 | $6,312 |
| Arthrex | 33 | $2,925 |
| Music City Medical Technologies, LLC | 11 | $1,949 |
| Zimvie Inc. | 2 | $893 |
| Zimmer Biomet | 1 | $436 |
| EBI, LLC | 1 | $373 |
| Si-bone, Inc. | 1 | $102 |
| Solventum Corporation | 1 | $23 |
| Augmedics Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST XT$19,102
- EVEREST MI$7,000
- SAHARA$6,500
- LATERAL ACCESS SPINAL SYSTEM$6,500
- CASCADIA$5,900
- TRITANIUM$5,682
- REVERE 6.35 Degen Ti System$5,280
- GENERAL K2M PRODUCT DISCUSSION$5,057
- NEW PRODUCT DEVELOPMENT$2,382
- Biomet SpinalPak Non-invasive Spine Fusion Stimulator System$1,266
- REVERE$650
- Biomet SpinalPak / OrthoPak$436
- NAVIGATOR$182
- YUKON$182
- Excelsius - GPS$113
- RAVINE$102
- CAPRI$102
- iFuse Implant$102
How this compares
$40,310 in reported general payments places this provider in the 70th percentile of 51 orthopaedic surgery of the spine providers in Tennessee.
See all orthopaedic surgery of the spine providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 44 | $452 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $327 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $290 |
| Methylprednisolone | 39 | $270 |
| Cephalexin | 17 | $199 |
| Pregabalin | 11 | $123 |
| Tramadol Hcl | 35 | $120 |
| Diclofenac Sodium | 22 | $102 |
| Cyclobenzaprine Hcl | 21 | $76 |
| Meloxicam | 16 | $37 |
| Naproxen | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Smyrna
- John BurlesonSmyrna$184K
- James FishSmyrna$6K
- Lawrence BabatNashville$928K
- Raymond GardockiNashville$666K
- Samuel SchroerluckeMemphis$451K
- James JolleyChattanooga$231K
- Michael McNamaraFranklin$150K
- John KlekampFranklin$148K
- Daniel WellsKnoxville$135K
- Colin CrosbyNashville$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.